Delivery Order SPE2DB22D2009-SPE2DB23FM4CE
Award Date 9/14/23
Potential Completion Date 9/15/23
Potential Value $188
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $12,780 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac injection vials. The one-day contract has a period of performance from September 25-26, 2023 for product delivery. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The brief contract aligns with the...
- The Defense Logistics Agency awarded a $72,920 delivery order to Amerisourcebergen Drug Corporation for 4561464899 ketorolac injection vials. The firm fixed price order is for delivery of the pharmaceutical product to a location in Conshohocken, Pennsylvania, with performance required from July 11-12, 2023. As a major distributor of medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order to support treatment needs at military medical facilities within the Defense...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $29,135.34 to Amerisourcebergen Drug Corporation for ketorolac injectable solution. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning August 28 through 29, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for a non-opioid pain reliever supports the Agency's mission to provide critical medicines and...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately ninety-five thousand dollars to Amerisourcebergen Drug Corporation for ketorolac injection vials. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period in late September 2023. No subcontractors or set aside designations were indicated. This order is likely placed against DLA's Pharmaceutical Prime Vendor contract, which provides pharmaceuticals and...
- The Defense Logistics Agency awarded a delivery order valued at $2,605.10 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/ml vials. This firm fixed-price delivery order, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a non-competitive, non-set-aside procurement of this pharmaceutical product. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $1,163.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/mL vial supply on September 22, 2025, with completion targeted for September 23, 2025. This is a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transactional purchase under a larger contract vehicle supporting the federal government's...
- The Defense Logistics Agency awarded a $7,130.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ketorolac 30 mg/ml vials. This non-set-aside contract is scheduled for completion by June 2, 2025, and represents a routine pharmaceutical procurement supporting federal medical supply needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $28,560 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac 30 mg/ml vials. The single day contract has a period of performance from June 20, 2023 through June 21, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this delivery order for the analgesic...
- The Defense Logistics Agency awarded a $12,780 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac injection vials. The one-day contract has a period of performance from September 25-26, 2023 for the pharmaceutical product. DLA will provide funding for the vials which Amerisourcebergen will deliver from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were specified. The order is likely associated with DLA's medical supply...
- The Defense Logistics Agency awarded a $1,597.07 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/mL vials on November 9, 2025, with completion scheduled for November 10, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB23FM4CEDelivery Order
The Defense Logistics Agency awarded a $187,740 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac injection vials. The one-day contract has a period of performance from September 14 to 15, 2023 for delivery to a location in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense globally, this order for a nonsteroidal anti-inflammatory drug supports the Agency's mission to provide critical medicines and medical materiel to military treatment facilities and units worldwide.
Generated 12/18/23, 8:30 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $188 | 9/14/23 |